In tumor-bearing mice, it reduces MDSC recruitment, enhances MHCII+ TAMs with a pro-inflammatory M1 phenotype, and promotes CD8+ T cell infiltration and activation within the tumor [213]. Here, CD8A is linked to neoplasm.